Subscribe To
KRON / Kronos Bio Announces Participation in Upcoming Investor Conferences
KRON News
By Zacks Investment Research
May 10, 2023
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Misses Revenue Estimates
Kronos Bio, Inc. (KRON) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to los more_horizontal
By Market Watch
January 9, 2023
Kronos Bio's stock rallies after announcing drug-discovery deal with Roche
Shares of Kronos Bio Inc. KRON, +2.38% jumped 25% in premarket trading on Monday after the company announced a development deal with Roche Holding's R more_horizontal
By Zacks Investment Research
December 12, 2022
Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 31% in 4 Weeks
Kronos Bio, Inc. (KRON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal
By Zacks Investment Research
November 22, 2022
Here's Why Kronos Bio, Inc. (KRON) is Poised for a Turnaround After Losing 23.8% in 4 Weeks
Kronos Bio, Inc. (KRON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal
By GlobeNewsWire
June 1, 2022
Kronos Bio Announces Participation in Upcoming Investor Conferences
SAN MATEO, Calif. and CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the liv more_horizontal